価格表

在庫・価格 : 2024年05月22日 22時57分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Mouse Nephrin ELISA Kit
データシート※最新のデータシートでない場合があります
1037 EXOエクソセル
EXOCELL Division of Ethos Biosciences, Inc.
1 kit ¥194,000
(未発注)
追加

在庫・価格 : 2024年05月22日 22時57分 現在

Mouse Nephrin ELISA Kit

  • 商品コード:1037
  • メーカー:EXO
  • 包装:1kit
  • 価格: ¥194,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Rautureau Y et al. Inducible human endothelin-1 overexpression in endothelium raises blood pressure via endothelin type A receptors. Hypertension 2015 Aug;66(2):347-55
Rautureau Y et al
2015/01/01
PubMed
2 Rossi E et al. Endoglin regulates mural cell adhesion in the circulatory system. Cell. Mol. Life Sci. 2016 Apr;73(8):1715-39
Rossi E et al
2016/01/01
PubMed
3 Heimlich JB et al. Endothelin-1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen species. Br. J. Pharmacol. 2016 Jan;173(2):386-95
Heimlich JB et al
2016/01/01
PubMed
4 Eun Lee J et al. DA-1229, a dipeptidyl peptidase IV inhibitor, protects against renal injury by preventing podocyte damage in an animal model of progressive renal injury. Lab. Invest. 2016 05;96(5):547-60
Eun Lee J et al
2016/01/01
PubMed
5 Cha JJ et al. Renal protective effects of toll-like receptor 4 signaling blockade in type 2 diabetic mice. Endocrinology 2013 Jun;154(6):2144-55
Cha JJ et al
2013/01/01
PubMed
6 Thieme K et al. EP4 inhibition attenuates the development of diabetic and non-diabetic experimental kidney disease. Sci Rep 2017 06;7(1):3442
Thieme K et al
2017/01/01
PubMed
7 Jung E et al. Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy. Eur. J. Pharmacol. 2015 Aug;761:116-24
Jung E et al
2015/01/01
PubMed
8 O"Brien SP et al. Glomerulopathy in the KK.Cg-A(y) /J mouse reflects the pathology of diabetic nephropathy. J Diabetes Res 2013;2013:498925
O"Brien SP et al
2013/01/01
PubMed
9 Min HS et al. Renoprotective Effects of a Highly Selective A3 Adenosine Receptor Antagonist in a Mouse Model of Adriamycin-induced Nephropathy. J. Korean Med. Sci. 2016 Sep;31(9):1403-12
Min HS et al
2016/01/01
PubMed
10 Wu X et al. Genetic modulation of diabetic nephropathy among mouse strains with Ins2 Akita mutation. Physiol Rep 2014 Nov;2(11)
Wu X et al
2014/01/01
PubMed
11 Pye C et al. Adenosine kinase inhibition protects the kidney against streptozotocin-induced diabetes through anti-inflammatory and anti-oxidant mechanisms. Pharmacol. Res. 2014 Jul;85:45-54
Pye C et al
2014/01/01
PubMed
12 Elmarakby AA et al. Tyrosine kinase inhibitor, genistein, reduces renal inflammation and injury in streptozotocin-induced diabetic mice. Vascul. Pharmacol. ;55(5-6):149-56
Elmarakby AA et al
PubMed
13 Tahara A et al. Prevention of progression of diabetic nephropathy by the SGLT2 inhibitor ipragliflozin in uninephrectomized type 2 diabetic mice. Eur. J. Pharmacol. 2018 Jul;830:68-75
Tahara A et al
2018/01/01
PubMed
14 Tahara A et al. Effects of the SGLT2 inhibitor ipragliflozin on various diabetic symptoms and progression of overt nephropathy in type 2 diabetic mice. Naunyn Schmiedebergs Arch. Pharmacol. 2018 04;391(4):395-406
Tahara A et al
2018/01/01
PubMed
15 Kandasamy Y et al. Nephrin - a biomarker of early glomerular injury. Biomark Res 2014;2:21
Kandasamy Y et al
2014/01/01
PubMed
16 Saleh MA et al. Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation. J. Clin. Invest. 2015 Mar;125(3):1189-202
Saleh MA et al
2015/01/01
PubMed
17 Cechova S et al. <i>MYH9</i> E1841K Mutation Augments Proteinuria and Podocyte Injury and Migration. J. Am. Soc. Nephrol. 2018 01;29(1):155-167
Cechova S et al
2018/01/01
PubMed
18 Mohamed R et al. Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis. J. Am. Soc. Nephrol. 2016 Mar;27(3):745-65
Mohamed R et al
2016/01/01
PubMed
19 Rubio-Navarro A et al. Podocytes are new cellular targets of haemoglobin-mediated renal damage. J. Pathol. 2018 03;244(3):296-310
Rubio-Navarro A et al
2018/01/01
PubMed
20 Elmarakby AA et al. Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats. Clin. Sci. 2013 Oct;125(7):349-59
Elmarakby AA et al
2013/01/01
PubMed
21 Heimlich JB et al. ET-1 increases reactive oxygen species following hypoxia and high-salt diet in the mouse glomerulus. Acta Physiol (Oxf) 2015 Mar;213(3):722-30
Heimlich JB et al
2015/01/01
PubMed
22 Mohamed R et al. Urinary semaphorin 3A correlates with diabetic proteinuria and mediates diabetic nephropathy and associated inflammation in mice. J. Mol. Med. 2014 Dec;92(12):1245-56
Mohamed R et al
2014/01/01
PubMed
23 Elmarakby AA et al. Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011 Nov;301(5):R1307-17
Elmarakby AA et al
2011/01/01
PubMed
24 Chang JH et al. Diabetic kidney disease in FVB/NJ Akita mice: temporal pattern of kidney injury and urinary nephrin excretion. PLoS ONE 2012;7(4):e33942
Chang JH et al
2012/01/01
PubMed
25 Wang W et al. Protective effects of aliskiren and valsartan in mice with diabetic nephropathy. J Renin Angiotensin Aldosterone Syst 2014 Dec;15(4):384-95
Wang W et al
2014/01/01
PubMed
  • No.: 1
  • 文献情報:
    Rautureau Y et al. Inducible human endothelin-1 overexpression in endothelium raises blood pressure via endothelin type A receptors. Hypertension 2015 Aug;66(2):347-55
    Rautureau Y et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Rossi E et al. Endoglin regulates mural cell adhesion in the circulatory system. Cell. Mol. Life Sci. 2016 Apr;73(8):1715-39
    Rossi E et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Heimlich JB et al. Endothelin-1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen species. Br. J. Pharmacol. 2016 Jan;173(2):386-95
    Heimlich JB et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Eun Lee J et al. DA-1229, a dipeptidyl peptidase IV inhibitor, protects against renal injury by preventing podocyte damage in an animal model of progressive renal injury. Lab. Invest. 2016 05;96(5):547-60
    Eun Lee J et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Cha JJ et al. Renal protective effects of toll-like receptor 4 signaling blockade in type 2 diabetic mice. Endocrinology 2013 Jun;154(6):2144-55
    Cha JJ et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Thieme K et al. EP4 inhibition attenuates the development of diabetic and non-diabetic experimental kidney disease. Sci Rep 2017 06;7(1):3442
    Thieme K et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Jung E et al. Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy. Eur. J. Pharmacol. 2015 Aug;761:116-24
    Jung E et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    O&quot;Brien SP et al. Glomerulopathy in the KK.Cg-A(y) /J mouse reflects the pathology of diabetic nephropathy. J Diabetes Res 2013;2013:498925
    O&quot;Brien SP et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Min HS et al. Renoprotective Effects of a Highly Selective A3 Adenosine Receptor Antagonist in a Mouse Model of Adriamycin-induced Nephropathy. J. Korean Med. Sci. 2016 Sep;31(9):1403-12
    Min HS et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Wu X et al. Genetic modulation of diabetic nephropathy among mouse strains with Ins2 Akita mutation. Physiol Rep 2014 Nov;2(11)
    Wu X et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Pye C et al. Adenosine kinase inhibition protects the kidney against streptozotocin-induced diabetes through anti-inflammatory and anti-oxidant mechanisms. Pharmacol. Res. 2014 Jul;85:45-54
    Pye C et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Elmarakby AA et al. Tyrosine kinase inhibitor, genistein, reduces renal inflammation and injury in streptozotocin-induced diabetic mice. Vascul. Pharmacol. ;55(5-6):149-56
    Elmarakby AA et al
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Tahara A et al. Prevention of progression of diabetic nephropathy by the SGLT2 inhibitor ipragliflozin in uninephrectomized type 2 diabetic mice. Eur. J. Pharmacol. 2018 Jul;830:68-75
    Tahara A et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Tahara A et al. Effects of the SGLT2 inhibitor ipragliflozin on various diabetic symptoms and progression of overt nephropathy in type 2 diabetic mice. Naunyn Schmiedebergs Arch. Pharmacol. 2018 04;391(4):395-406
    Tahara A et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Kandasamy Y et al. Nephrin - a biomarker of early glomerular injury. Biomark Res 2014;2:21
    Kandasamy Y et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Saleh MA et al. Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation. J. Clin. Invest. 2015 Mar;125(3):1189-202
    Saleh MA et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Cechova S et al. <i>MYH9</i> E1841K Mutation Augments Proteinuria and Podocyte Injury and Migration. J. Am. Soc. Nephrol. 2018 01;29(1):155-167
    Cechova S et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Mohamed R et al. Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis. J. Am. Soc. Nephrol. 2016 Mar;27(3):745-65
    Mohamed R et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Rubio-Navarro A et al. Podocytes are new cellular targets of haemoglobin-mediated renal damage. J. Pathol. 2018 03;244(3):296-310
    Rubio-Navarro A et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Elmarakby AA et al. Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats. Clin. Sci. 2013 Oct;125(7):349-59
    Elmarakby AA et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Heimlich JB et al. ET-1 increases reactive oxygen species following hypoxia and high-salt diet in the mouse glomerulus. Acta Physiol (Oxf) 2015 Mar;213(3):722-30
    Heimlich JB et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Mohamed R et al. Urinary semaphorin 3A correlates with diabetic proteinuria and mediates diabetic nephropathy and associated inflammation in mice. J. Mol. Med. 2014 Dec;92(12):1245-56
    Mohamed R et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Elmarakby AA et al. Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011 Nov;301(5):R1307-17
    Elmarakby AA et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Chang JH et al. Diabetic kidney disease in FVB/NJ Akita mice: temporal pattern of kidney injury and urinary nephrin excretion. PLoS ONE 2012;7(4):e33942
    Chang JH et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Wang W et al. Protective effects of aliskiren and valsartan in mice with diabetic nephropathy. J Renin Angiotensin Aldosterone Syst 2014 Dec;15(4):384-95
    Wang W et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed